TrialsTracker Reveals that Nearly Half of All Clinical Trials Go Unpublished | Pharmaguy's Insights Into Drug Industry News |

Around half of all trials run by pharma companies, universities and other major research sponsors remain unpublished, according to a tool built to promote greater trial transparency.


The TrialsTracker monitors, the world's largest clinical trial register, for whether or not studies have been published two years after their stated end date.


Collecting data from January 2006 to November 2014, the tracker found that 45% of the 25,927 eligible trials had not had their results published.


The TrialsTracker was created by a team of academics at the University of Oxford that includes Dr Ben Goldacre, author of Bad Pharma and one of the founders of the AllTrials campaign for clinical trial transparency.


“Everyone has been talking about this problem for far too long. We hope that increasing accountability will help to drive change forward,” he said.


“The TrialsTracker helps to identify the individual universities and companies with the most overdue trials. If any institution is concerned that it is doing badly in our league tables, then there is one simple thing they can do: publish their trial results, using their trial registry number, so that this information can be accessed and read by doctors, researchers, and patients.”